Literature DB >> 23809889

The activation of vivax malaria hypnozoites by infectious diseases.

G Dennis Shanks1, Nicholas J White.   

Abstract

The periodicity of vivax malaria relapses may be explained by the activation of latent hypnozoites acquired from a previous malarial infection. The activation stimulus could be the febrile illness associated with acute malaria or a different febrile infection. We review historical records to examine the association between relapses of Plasmodium vivax and febrile infectious diseases. In data from British soldiers in Palestine, epidemic falciparum malaria triggered a smaller epidemic of P vivax relapses only in those who had been extensively exposed to malaria previously. Relapses did not follow pandemic influenza infection. Evidence from three simultaneous typhoid and malaria epidemics suggest that typhoid fever might activate P vivax hypnozoites. Some data lend support to the notion that vivax malaria relapse followed febrile illness caused by relapsing fever, trench fever, epidemic typhus, and Malta fever (brucellosis). These observations suggest that systemic parasitic and bacterial infections, but not viral infections, can activate P vivax hypnozoites. Specific components of the host's acute febrile inflammatory response, and not fever alone, are probably important factors in the provocation of a relapse of vivax malaria.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23809889     DOI: 10.1016/S1473-3099(13)70095-1

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  59 in total

Review 1.  Tafenoquine and G6PD: a primer for clinicians.

Authors:  Cindy S Chu; David O Freedman
Journal:  J Travel Med       Date:  2019-06-01       Impact factor: 8.490

2.  Receptor-mediated hepatocyte-targeted delivery of primaquine phosphate nanocarboplex using a carbohydrate ligand.

Authors:  Vishvesh M Joshi; Padma V Devarajan
Journal:  Drug Deliv Transl Res       Date:  2014-08       Impact factor: 4.617

Review 3.  Hypothesis: dynamics of classical malaria epidemics show Plasmodium falciparum's survival strategy.

Authors:  G Dennis Shanks
Journal:  Am J Trop Med Hyg       Date:  2015-01-26       Impact factor: 2.345

Review 4.  Selection and refinement: the malaria parasite's infection and exploitation of host hepatocytes.

Authors:  Alexis Kaushansky; Stefan Hi Kappe
Journal:  Curr Opin Microbiol       Date:  2015-06-21       Impact factor: 7.934

5.  [Malaria].

Authors:  G D Burchard
Journal:  Internist (Berl)       Date:  2014-02       Impact factor: 0.743

Review 6.  Opportunities for Host-targeted Therapies for Malaria.

Authors:  Elizabeth K K Glennon; Selasi Dankwa; Joseph D Smith; Alexis Kaushansky
Journal:  Trends Parasitol       Date:  2018-08-16

7.  Novel Insights into Plasmodium vivax Therapeutic Failure: CYP2D6 Activity and Time of Exposure to Malaria Modulate the Risk of Recurrence.

Authors:  Ana Carolina Rios Silvino; Flora Satiko Kano; Marcelo Azevedo Costa; Cor Jesus Fernandes Fontes; Irene Silva Soares; Cristiana Ferreira Alves de Brito; Luzia Helena Carvalho; Tais Nobrega Sousa
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

8.  Plasmodium vivax Infections over 3 Years in Duffy Blood Group Negative Malians in Bandiagara, Mali.

Authors:  Amadou Niangaly; Drissa Coulibaly; Juliana M Sá; Matthew Adams; Mark A Travassos; Jennifer Ferrero; Matthew B Laurens; Abdoulaye K Kone; Mahamadou A Thera; Christopher V Plowe; Louis H Miller; Ogobara K Doumbo
Journal:  Am J Trop Med Hyg       Date:  2017-07-27       Impact factor: 2.345

9.  Synergistic Mortality Caused by Plasmodium falciparum During the 1918 Influenza Pandemic.

Authors:  G Dennis Shanks
Journal:  Am J Trop Med Hyg       Date:  2015-03-23       Impact factor: 2.345

10.  EVALUATION OF CIRCUMSPOROZOITE PROTEIN OF Plasmodium vivax TO ESTIMATE ITS PREVALENCE IN OIAPOQUE , AMAPÁ STATE, BRAZIL, BORDERING FRENCH GUIANA.

Authors:  Margarete do Socorro Mendonça Gomes; José Luiz Fernandes Vieira; Gustavo Capatti Cassiano; Lise Musset; Eric Legrand; Mathieu Nacher; Vanja Suely Calvosa D'Almeida Couto; Ricardo Luiz Dantas Machado; Álvaro Augusto Ribeiro D'Almeida Couto
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-09-22       Impact factor: 1.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.